According to an official statement from Wattle, the products in the range are made completely from Australian fruit and vegetables purchased from Indian firm Vasudevan and Sons Exim Pte Ltd.
This represents a significant milestone for the company, as it has received approval under India's strict and extensive regulatory food import system.
In addition, this provides the firm with plenty of business opportunities in a country where nearly 50% of the population is below the age of 25.
Expectations for expansion
Apart from India, Wattle has also released its natural baby food range in China, whose infant nutrition market — alongside that in India — is among the world's fastest-growing.
The company intends to continue expanding its product portfolio and increasing both its domestic and international presence, in order to minimise its risk profile and dependence on products and jurisdictions.
Executive chairman Lazarus Karasavvidis said: "This order has allowed Wattle Health to enter one of the fastest-growing and most dynamic economies.
"We will take advantage of this opportunity to enter the Indian market and use it to increase distribution channels for our baby food range. We will also look to grow our presence and increase our footprint in this exciting market."
Opportunity via legality
Recently, we reported that Wattle had secured a 'brand slot' with a licensed manufacturer in China.
Amid the goat milk formula boom in China, the firm plans to use this as a platform to gain CFDA (China Food and Drug Administration) for its goat milk infant formula, after having received approval for its cow milk formula last year.